Trial Profile
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 27 Aug 2018 Status changed from not yet recruiting to withdrawn prior to enrolment due to lost of funding.
- 08 Jun 2018 Planned initiation date changed from 1 Feb 2018 to 1 Jul 2018.
- 12 Jan 2018 Planned initiation date changed from 1 Oct 2017 to 1 Feb 2018.